Humacyte, Inc. (HUMA)
$0.41-8.89%Close
SELLCRISIS · day 29
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $69M
- Beta
- 2.45
- P/E (TTM)
- -0.94
- Short % float
- 21.29%
- Days to cover
- 7.3
- SI change
- -7.6%
- 1W
- -21.15%
- 1M
- -28.07%
- vs SPY 1W
- -22.31%
- vs SPY 1M
- -31.06%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on HUMA?
- LOPJLB’s latest quantitative signal on Humacyte, Inc. (HUMA) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is HUMA in?
- Humacyte, Inc. (HUMA) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Humacyte, Inc. (HUMA) do?
- Humacyte, Inc. focuses on developing and manufacturing readily available, implantable human tissues engineered in a laboratory setting. These bioengineered tissues are designed to treat a wide array of diseases and conditions across various anatomical locations and therapeutic fields. The company employs its distinct scientific and proprietary technology platform to produce human acellular vess…